纳米生物技术,无机纳米材料,有机纳米材料,纳米药物研究方面的研究文献,上学时读的文献,现在没用了,放在电脑里占内存,丢掉有点可惜,现免费分享给大家。


Liposomesandvirosomesasdeliverysystemsforantigens,nucleicacidsanddrugs
Lipid-basedvesiclesareaverypromisingapproachtotreatdiseasessuchascancer,chronicinfectionsand
auto-immunity.Moderndrugencapsulationmethodsallowef cientpackingoftherapeuticsubstancesinsideliposomes,therebyreducingthesystemictoxicityofthedrugs.Speci ctargetingcanenhancethetherapeuticeffectofthedrugsthroughtheiraccumulationatthediseasedsite.Inthevaccine eld,theintegrationoffunctionalviralenvelopeproteinsintoliposomeshasledtoanantigencarrieranddeliverysystemtermedavirosome,aclinicallyprovenvaccineplatformforsubunitvaccineswithanexcellentimmunogenicityandtolerabilitypro le.
Addresses
BernaBiotechLtd,Rehhagstrasse79,CH-3018,Berne,SwitzerlandÃ
e-mail:diana.felnerova@bernabiotech.com
¨ckandChristianMoserDianaFelnerovaÃ,Jean-Franc¸oisViret,ReinhardGlu
autoimmunediseases,aswellashormonaldysregulation.
Sophisticatedformulations(e.g.PEGylated‘stealth’lipo-somes)havebeendevelopedandtheirsuperiorpropertiesdemonstratedwithregardtostability,pharmacokinetics,biodistributionandtoxicity.Despiteextensivestudiesandsigni cantimprovementsinthetechnologyoverthepastthreedecades,thecommercialsuccessofliposometechnologyisstilllimitedexceptforcosmeticproductsthatarenotdiscussedhere.Onlyfourliposomalformula-tionshavereachedthemarketforthedeliveryofdrugsviaintravenousadministration(Table1).Liposomalformu-lationsofseveralsubstancessuchascaryostatics,anti-biotics,photosensitizers,enzymes,hormones,cytokinesandnucleicacids(e.g.oligonucleotidesforgenedelivery)arecurrentlyinpreclinicalandclinicaldevelopmentwithpromisingresults(Tables2and3).Theuseofliposometechnologyingenetherapyhasbeenextensivelyinves-tigated,butthelowef ciencybothofgenetransferandexpressioninvivoremainsthemajorhurdletosuccessfulapplication.Withregardtovaccinesliposomes,andinparticulartheso-calledvirosomes,possessattractivechar-acteristicsasavaccinecarrierandadjuvantsystem[3].Virosomesareliposomalformulationsthathaveviralenvelopeproteinsanchoredintheirlipidmembrane.Thesevirus-likeparticleshaveproventobeeffectiveimmunogenswithuniqueadjuvantproperties[4 ].Inaddition,promisingdatahavebeengeneratedwithotherlipid-basedcarrier/adjuvantsystems,suchastransfero-somes(liposomesconsistingofphosphatidylcholineandcholatewithenhancedskinpenetratingpropertiesforcutaneousadministration),archaesomes(liposomespre-paredusingarchaeobacteriamembranelipidsthatarereportedtoinducesuperiorimmuneresponsescompar-abletoimmunizationwithcompleteFreund’sadjuvant),niosomes(non-ionicsurfactantvesicleswithenhancedchemicalstability),cochleates(formedfromnon-vesicu-larbilayersheetsconsistingofphosphatidylethanola-mine,phosphatidylserineandcholesterolintercalatedbycalciumions)orproteosomes(preparedbyrecon-stitutionofthebacterialoutermembraneandcom-prisedmainlyfromproteins;theyprovidehighim-munogenicity)[5].
CurrentOpinioninBiotechnology2004,15:518–529ThisreviewcomesfromathemedissueonPharmaceuticalbiotechnology
EditedbyCarlosAGuzmanandGioraZFeuersteinAvailableonline28thOctober20040958-1669/$–seefrontmatter
#2004ElsevierLtd.Allrightsreserved.DOI10.1016/j.copbio.2004.10.005
AbbreviationsAPCantigen-presentingcellHAhemagglutininIRIVimmunopotentiatingreconstitutedin uenzavirosomesMHCmajorhistocompatibilitycomplexPEGpolyethyleneglycol
Introduction
Liposomesarevesiclesofvaryingsizeconsistingofasphericallipidbilayerandanaqueousinnercompartmentthataregeneratedinvitro.Thedistinctadvantageofliposomesistheirabilitytoencapsulatevariousmaterialscombinedwiththeirstructuralversatility.In1965,Banghametal. rstusedaliposomalstructureasamodeltostudytheeffectofnarcoticsonlipidbilayermembranes[1].Nineyearslater,AllisonandGregoriadisdescribedtheuseofasimilarliposomalsystemasanimmunologicaladjuvant[2].
Sincetheseearlyexperiments,liposomeshavebecomeanestablishedcarrieranddeliverysysteminthe eldofpharmaco-andimmuno-therapy.Liposomalcarriershavebeenusedforthetreatmentofcancer,infectiousand
CurrentOpinioninBiotechnology2004,15:518–529
Advantagesofliposomaldeliverysystems
Twoofthekeyproblemsofpharmaco-/immuno-therapy—biodistributionandtargeting—canbeaddressedand,atleastpartially,solvedbytheuseofliposomalformulations.Aliposomecanprotectitspay-load(e.g.anactivedrug)fromtheenvironment(e.g.inblood)andviceversa,untilcontrolledreleaseoccursatthetargetsite.Thelipidmembraneanditssurfaceare
doc.guandang.net
as monoclonal antibodies, liposomes, polymers, dendrimers, micelles, and ...to the delivery of antigens to dendritic cells for active tumor immunotherapy...
as monoclonal antibodies, liposomes, polymers, dendrimers, micelles, and ...to the delivery of antigens to dendritic cells for active tumor immunotherapy...
热门文档